PT Diastika Biotekindo TbkISX:CHEK +0.81% Market Cap is Rp510,053.10 Mil as of Jul. 13, 2026. The stock has 1 warning sign investors should review. Among 866 Medical Devices & Instruments companies, PT Diastika Biotekindo Tbk ranks worse than 72.06% on this metric.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Diastika Biotekindo Tbk's Enterprise Value for Today is Rp510,053.10 Mil.
PT Diastika Biotekindo Tbk (ISX:CHEK) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT Diastika Biotekindo Tbk Market Cap Related Terms
PT Diastika Biotekindo Tbk Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diastika Biotekindo Tbk Market Cap Chart
PT Diastika Biotekindo Tbk Annual Data
Trend
Market Cap
PT Diastika Biotekindo Tbk Semi-Annual Data
Market Cap
ISX:CHEK vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, PT Diastika Biotekindo Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Diastika Biotekindo Tbk Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Diastika Biotekindo Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Diastika Biotekindo Tbk's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diastika Biotekindo Tbk (ISX:CHEK) has a Market Cap of Rp510,053.10 Mil as of Jul. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Diastika Biotekindo Tbk and its competitors. According to the industry distribution chart, PT Diastika Biotekindo Tbk ranks #624 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 72.1%.
Is PT Diastika Biotekindo Tbk's Market Cap too high?
PT Diastika Biotekindo Tbk's current Market Cap is Rp510,053.10 Mil. Based on the distribution chart, PT Diastika Biotekindo Tbk ranks #624 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does PT Diastika Biotekindo Tbk's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT Diastika Biotekindo Tbk ranks #624 out of 866 companies for Market Cap. This places PT Diastika Biotekindo Tbk in the lower half of its industry. The industry median Market Cap is 119.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 119.65, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Diastika Biotekindo Tbk and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 119.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Diastika Biotekindo Tbk's current Market Cap is Rp510,053.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current Market Cap of Rp510,053.10 Mil. The current Market Cap is Rp510,053.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current Market Cap is Rp510,053.10 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressJalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CHEK has been successfully added to your